Whetstone Capital Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PRO
PROS Holdings
PRO
|
+$6.31M |
| 2 |
Inspire Medical Systems
INSP
|
+$3.32M |
| 3 |
DexCom
DXCM
|
+$580K |
| 4 |
Veeva Systems
VEEV
|
+$377K |
| 5 |
Toast
TOST
|
+$359K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SentinelOne
S
|
+$6.48M |
| 2 |
SEMR
Semrush
SEMR
|
+$4.46M |
| 3 |
monday.com
MNDY
|
+$2.38M |
| 4 |
Taboola.com
TBLA
|
+$1.52M |
| 5 |
VMEO
Vimeo
VMEO
|
+$1.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 72.1% |
| 2 | Communication Services | 15.85% |
| 3 | Consumer Discretionary | 7.67% |
| 4 | Healthcare | 2.85% |
| 5 | Financials | 1.54% |
Similar funds
Whetstone Capital Advisors's Q4 2023 Portfolio in Review
As of Q4 2023, Whetstone Capital Advisors held 38 positions worth $199M, up 10% from $181M the previous quarter. Its ten largest holdings account for 69% of the portfolio.
Whetstone Capital Advisors withdrew a net $9.87M in Q4 2023, closing 8 positions and reducing 10 holdings. Its most notable exit was SentinelOne, an estimated $6.48M position sold in full.
By sector, the portfolio is most concentrated in Technology at 72% of assets, down from 74% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Whetstone Capital Advisors opened a new position in Inspire Medical Systems worth $4.17M.
- Whetstone Capital Advisors's largest Q4 2023 buy was Inspire Medical Systems: 20,509 shares worth $4.17M.
- Whetstone Capital Advisors added most to PROS Holdings in Q4 2023, an estimated $6.31M increase.
- Whetstone Capital Advisors's biggest Q4 2023 reduction was monday.com, cutting an estimated $2.38M.
- Whetstone Capital Advisors fully exited SentinelOne in Q4 2023, selling an estimated $6.48M.
- Whetstone Capital Advisors's ten largest holdings make up 69% of its $199M portfolio in Q4 2023.
- Whetstone Capital Advisors opened 3 new positions and closed 8 in Q4 2023.
- Whetstone Capital Advisors's portfolio value rose 10% quarter-over-quarter to $199M.
Based on Whetstone Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.